The Eagle has not yet landedTo review the April 21 Market Herald statement: The company is sending Eagle samples to a new lab to expedite turnaround times. Initial assay results from the Phase I program at Eagle are expected to be released in Q2/2022.
Cavaet - I'm not down on the company. However, it's been quiet and recent performance, while off the lows, has obviously been a downer. Wondering what June 9-30 may hold in regard to news releases. Not necessarily an issue of the longer term outlook, however the company itself indicated we'd hear something. Anyone concerned? Per usual, who can know what's going on behind the scenes? GLTA